{"id":652347,"date":"2023-05-22T17:00:06","date_gmt":"2023-05-22T17:00:06","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=652347"},"modified":"2023-05-22T17:00:06","modified_gmt":"2023-05-22T17:00:06","slug":"west-syndrome-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032-key-companies-mallinckrodt-pharmaceuticals-insys-therapeutics-gw-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/west-syndrome-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032-key-companies-mallinckrodt-pharmaceuticals-insys-therapeutics-gw-pharmaceuticals_652347.html","title":{"rendered":"West Syndrome Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032)| Key Companies &#8211; Mallinckrodt Pharmaceuticals, INSYS Therapeutics GW Pharmaceuticals,"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"West Syndrome Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032)| Key Companies - Mallinckrodt Pharmaceuticals, INSYS Therapeutics GW Pharmaceuticals,\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" alt=\"West Syndrome Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032)| Key Companies - Mallinckrodt Pharmaceuticals, INSYS Therapeutics GW Pharmaceuticals,\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;West Syndrome Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the West Syndrome, historical and forecasted epidemiology as well as the West Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan<\/div>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s&nbsp;<strong>&#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/west-syndrome-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\" target=\"_blank\">West Syndrome Market Insights, Epidemiology, and Market Forecast-2032<\/a>&#8220;<\/strong>&nbsp;report delivers an in-depth understanding of the West Syndrome, epidemiology insights, West Syndrome market trends, therapies, and key companies working in the West Syndrome Market in the 7MM.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>West Syndrome Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">West syndrome is a constellation of symptoms characterized by epileptic\/infantile spasms, abnormal brain wave patterns called hypsarrhythmia, and intellectual disability. The spasms that occur may range from violent jackknife or &ldquo;salaam&rdquo; movements where the whole body bends in half, or they may be no more than a mild twitching of the shoulder or eye changes. These spasms usually begin in the early months after birth and can sometimes be helped with medication. They can also occur in older patients; if this happens, they are called &ldquo;epileptic spasms&rdquo; rather than infantile spasms. Currently, the International League Against Epilepsy (ILAE) has revised the terminology and epileptic spasms is now preferentially used to encompass the different age groups of onset. There are many different causes of epileptic spasms and if a specific cause can be identified, a diagnosis of symptomatic epileptic spasms can be made. If a cause cannot be determined, a diagnosis of cryptogenic epileptic spasms is made.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/9653d6cf0f52cafa31548068d7b5a5b8.png\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>West Syndrome Epidemiology Insights<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">West syndrome has been estimated to affect 31 per 1000 live births in the United States. West syndrome accounts for approximately 30 percent of all cases of epilepsy affecting infants.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Only 5 out of every 100 children diagnosed with West syndrome will not survive beyond the age of five years.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">Click here to learn more about the&nbsp; <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/west-syndrome-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\">West Syndrome Market Landscape<\/a><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>The Report Covers the&nbsp; West Syndrome Epidemiology Segmented by:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Total&nbsp; West Syndrome incident cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Total&nbsp; West Syndrome prevalent cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Total&nbsp; West Syndrome treatment cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Total&nbsp; West Syndrome diagnostic cases&nbsp;<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>&nbsp;West Syndrome Market Outlook&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The West Syndrome market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted West Syndrome market trends by analyzing the impact of current West Syndrome therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the West Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated West Syndrome market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the West Syndrome market in 7MM is expected to witness a major change in the study period 2019-2032.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Key Companies Working in the West Syndrome Market<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Mallinckrodt Pharmaceuticals<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">INSYS Therapeutics<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">GW Pharmaceuticals<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">BioPharm Solutions<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many others&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">&nbsp;<strong>West Syndrome Therapies Covered and Analyzed in the Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">H.P. Acthar&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Cannabidiol&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Epidiolex<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">JBPOS0101<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many others&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Learn more about the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/west-syndrome-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\">Key Companies and Emerging Therapies in the&nbsp; West Syndrome Market.<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents&nbsp;<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Key Insights&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;West Syndrome Introduction&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Executive Summary of&nbsp; West Syndrome&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Disease Background and Overview<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Epidemiology and patient population<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;West Syndrome Emerging Therapies<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;West Syndrome Market Outlook<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Market Access and Reimbursement of Therapies<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Market Drivers&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Market Barriers&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Appendix<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Report Methodology<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;DelveInsight Capabilities<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">&nbsp;Disclaimer<\/p>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Learn about the detailed offerings of the report @&nbsp; <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/west-syndrome-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=dpr\">West Syndrome Market Outlook. <\/a><\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_75707.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Adya Kaul<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=west-syndrome-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032-key-companies-mallinckrodt-pharmaceuticals-insys-therapeutics-gw-pharmaceuticals\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/consulting\/due-diligence-services<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=west-syndrome-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032-key-companies-mallinckrodt-pharmaceuticals-insys-therapeutics-gw-pharmaceuticals\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight&#8217;s &#8220;West Syndrome Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the West Syndrome, historical and forecasted epidemiology as well as the West Syndrome market trends in the United States, EU4 (Germany, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/west-syndrome-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20222032-key-companies-mallinckrodt-pharmaceuticals-insys-therapeutics-gw-pharmaceuticals_652347.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,417,406,403,404],"tags":[],"class_list":["post-652347","post","type-post","status-publish","format-standard","hentry","category-Business","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/652347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=652347"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/652347\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=652347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=652347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=652347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}